A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis

Journal of the American Academy of Dermatology
Steven KempersBeatrice Abrams

Abstract

To evaluate pimecrolimus cream 1% and tacrolimus ointment 0.03% in pediatric patients with moderate atopic dermatitis (AD). 141 patients (aged 2-17 years) were randomized to treatment with pimecrolimus cream 1% (n=71) or tacrolimus ointment 0.03% (n=70) twice daily for 6 weeks. At day 4, local, application-site reactions were less common and of shorter duration with pimecrolimus than with tacrolimus. Incidence of erythema/irritation was 8% (6/71) with pimecrolimus compared with 19% (13/70) with tacrolimus (P=.039). Fewer patients receiving pimecrolimus (0%, 0/6) experienced erythema/irritation lasting >30 minutes, compared with those receiving tacrolimus (85%, 11/13; P <.001). Fewer patients reported itching with pimecrolimus (8%; 6/71) than with tacrolimus (20%; 14/70; P=.073). Incidence of warmth, stinging, and burning was similar in both groups; however, reactions lasting >30 minutes were fewer with pimecrolimus (0%, 0/14) than with tacrolimus (67%, 8/12; P <.001). More patients receiving pimecrolimus rated ease of application as 'excellent' or 'very good', compared with tacrolimus (76% vs 59%, respectively; P <.020). Efficacy was similar in both groups at day 43. Both treatments were generally well tolerated with no unexpec...Continue Reading

References

May 8, 1999·The British Journal of Dermatology·J Linnet, G B Jemec
May 16, 2000·The British Journal of Dermatology·C R CharmanH C Williams
Jul 3, 2002·Pediatrics·Ulrich WahnUNKNOWN Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group
Jul 20, 2002·Current Opinion in Pediatrics·Laurie A Bernard, Lawrence F Eichenfield

❮ Previous
Next ❯

Citations

May 10, 2005·Immunology and Allergy Clinics of North America·Mark Boguniewicz
Feb 29, 2008·Pediatric Dermatology·Jun YanFeng-shan Wang
Aug 4, 2010·Pediatric Dermatology·Alexandra D McCollumLawrence F Eichenfield
Aug 10, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Thomas HultschJonathan Spergel
Feb 7, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Lawrence F EichenfieldCarle Paul
Feb 7, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Richard G B LangleyCarle Paul
Apr 1, 2005·American Journal of Clinical Dermatology·Kristine BreuerAlexander Kapp
Nov 3, 2009·Paediatric Drugs·Lily P H Yang, Monique P Curran
Jun 1, 2010·American Journal of Clinical Dermatology·Lily P H Yang, Monique P Curran
Nov 12, 2010·American Journal of Clinical Dermatology·Manjunatha Kalavala, Magdalene A Dohil
Dec 3, 2009·Journal of Neurosurgery. Spine·Berker CemilIbrahim Tekdemir
Dec 22, 2015·Journal of the American Academy of Dermatology·Masaki FutamuraEric L Simpson
Dec 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas WerfelUNKNOWN Association of Scientific Medical Societies of Germany
Jul 20, 2011·Seminars in Cutaneous Medicine and Surgery·Judith HongMartin Steinhoff
Jul 22, 2005·International Journal of Clinical Practice·Paolo GisondiGiampiero Girolomoni
Nov 5, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·J RingP van de Kerkhof
Aug 5, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas Werfel
Apr 2, 2009·International Journal of Dermatology·Sakari ReitamoNasrullah Undre
Sep 15, 2007·The British Journal of Dermatology·M H A Rustin
Jan 17, 2007·The British Journal of Dermatology·J CallenB U Wintroub
Jul 27, 2006·Allergy·C A AkdisUNKNOWN Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group
Apr 24, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·A P de MoraesM E A de Moraes
Sep 20, 2011·International Journal of Dermatology·Johanna M MandelinNasrullah Undre
Sep 14, 2011·The Mount Sinai Journal of Medicine, New York·Andrew SohnGary Goldenberg
Jun 22, 2005·Journal of the American Academy of Dermatology·William Abramovits
Apr 29, 2005·Journal of the American Academy of Dermatology·Amy S PallerUNKNOWN US/Canada Tacrolimus Ointment Study Group
May 13, 2014·Journal of the American Academy of Dermatology·Lawrence F EichenfieldRobert Sidbury
Jun 1, 2007·The Journal of Dermatological Treatment·Alan B FleischerUNKNOWN US/Canada tacrolimus ointment study group
Jul 16, 2010·The Annals of Pharmacotherapy·Antonia CarboneRupal Patel
Jul 2, 2015·The Cochrane Database of Systematic Reviews·Jade Cury MartinsEdina Mk da Silva
Oct 30, 2015·Annals of Dermatology·Hye One KimChun Wook Park
Feb 28, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Johannes RingVerena Henkel
Dec 1, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Dagmar SimonDirk Schneider
May 20, 2015·Dermatitis : Contact, Atopic, Occupational, Drug·Brian Keng Yong Chia, Hong Liang Tey
Sep 4, 2019·Journal of Cutaneous Medicine and Surgery·Sam HannaNeil H Shear
Sep 4, 2019·Journal of Cutaneous Medicine and Surgery·Loretta FiorilloMichele Ramien
Jan 27, 2019·Dermatology and Therapy·Zoe D DraelosSheryl Baldwin
Oct 19, 2007·The Cochrane Database of Systematic Reviews·D M AshcroftH C Williams
Aug 23, 2016·The British Journal of Dermatology·H NankervisH C Williams
Dec 15, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·T LugerC Traidl-Hoffmann
Dec 1, 2020·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Thomas LugerThomas Werfel
Dec 15, 2020·South African Family Practice : Official Journal of the South African Academy of Family Practice/Primary Care·Susanna M KannenbergThomas Luger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.